Ola Soderquist - Bioxytran CFO, Treasurer, Secretary

BIXT Stock  USD 0.13  0.02  13.33%   

CFO

Mr. Ola Soderquist is Chief Financial Officer, Treasurer, Secretary of the Company. He has more than 30 years of senior international entrepreneurial management experience within technology companies. Olas managerial experience portfolio includes Startups, Private, Public, VC and Private Equity ownership. He has served in CFO and other managerial capacities in multiple industry sectors and companies. His public company tenures include companies in the Wallenberg Sphere Industrivarden, Electrolux, Ericsson, Swedish Match and SKF AB, and most recently in Traction and Belden . His private company experience includes CFO and CAO positions in Proditec, Inc., LFA Corporationration and Faria Beede Instruments, Inc. . Ola is a multilingual senior finance professional poised to work globally and crossfunctionally, particularly with complex projects involving change management, business integration, systems implementation, continuous improvement, and process excellence. He obtained a BS and an M S in Accounting from Stockholm School of Economics and an MBA from Babson College. since 2018.
Tenure 6 years
Professional MarksMBA
Phone617 454 1199
Webhttps://www.bioxytraninc.com

Bioxytran Management Efficiency

The company has return on total asset (ROA) of (7.0399) % which means that it has lost $7.0399 on every $100 spent on assets. This is way below average. Bioxytran's management efficiency ratios could be used to measure how well Bioxytran manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 2.17 M in liabilities. Bioxytran has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Bioxytran until it has trouble settling it off, either with new capital or with free cash flow. So, Bioxytran's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioxytran sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioxytran to invest in growth at high rates of return. When we think about Bioxytran's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CFO Age

Alexander ArrowProtagenic Therapeutics
46
MD CFAProtagenic Therapeutics
53
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts. Bioxytran operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people. Bioxytran [BIXT] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Bioxytran Leadership Team

Elected by the shareholders, the Bioxytran's board of directors comprises two types of representatives: Bioxytran inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioxytran. The board's role is to monitor Bioxytran's management team and ensure that shareholders' interests are well served. Bioxytran's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioxytran's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anders Utter, Independent Director
Ola Soderquist, CFO, Treasurer, Secretary
Henry Esber, Independent Director
CMA CPA, Treasurer CFO
Michael BS, Chief Officer
Dale Conaway, Independent Director
David Platt, President CEO, Director
Alan Hoberman, Independent Director

Bioxytran Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bioxytran a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioxytran in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioxytran's short interest history, or implied volatility extrapolated from Bioxytran options trading.

Pair Trading with Bioxytran

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioxytran position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioxytran will appreciate offsetting losses from the drop in the long position's value.

Moving against Bioxytran OTC Stock

  0.43JNJ Johnson Johnson Aggressive PushPairCorr
  0.43BA Boeing Financial Report 24th of July 2024 PairCorr
The ability to find closely correlated positions to Bioxytran could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioxytran when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioxytran - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioxytran to buy it.
The correlation of Bioxytran is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioxytran moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioxytran moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioxytran can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioxytran. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Bioxytran OTC Stock analysis

When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Please note, there is a significant difference between Bioxytran's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioxytran is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioxytran's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.